Search Results

Valeant, Glaxo, Novartis Skin Drug Prices Have Soared.

• Authors : Detar, James

• Source: Investor's Business Daily. 2015.

Record details

FDA Speeds Merck Reviews For Hep C's Sickest Doublet Cured 78%-100% Gilead, AbbVie regimens aren't seriously affected, and stock prices reflect it.

• Authors : Reeves, Amy

• Source: Investor's Business Daily. 2015.

Record details

Teva, Horizon See Growth In Orphan-Drug Takeovers Auspex, Hyperion Adopted Commanding high prices for legal, market reasons, orphan drugs are popular.

• Authors : Reeves, Amy

• Source: Investor's Business Daily. 2015.

Record details

New Cancer Drugs May Shrink Tumors, Boost Stock Prices Anti-PD-1s In Clinical Trials Bristol-Myers treatment, besting current drugs, could launch next year.

• Authors : Reeves, Amy

• Source: Investor's Business Daily. 2013.

Record details

Roche cuts Indian drug prices.

• Source: Investor's Business Daily. 2012.

Record details

Big Drug M&A Activity Strong, But Takeovers Generally Weak; Off 10% So Far In '09; Would-be buyers wary to deal amid recession, despite lower prices.

• Source: Investor's Business Daily. 2009.

Record details

Big Drug M&A Activity Strong, But Takeovers Generally Weak Off 10% So Far In '09 Would-be buyers wary to deal amid recession, despite lower prices.

• Source: Investor's Business Daily. 2009.

Record details

Fairholme Sees Market Full Of Values; Holdings Include Pfizer; Manager Berkowitz likes basically sound stocks with distressed prices.

• Source: Investor's Business Daily. 2008.

Record details

Fairholme Sees Market Full Of Values Holdings Include Pfizer Manager Berkowitz likes basically sound stocks with distressed prices.

• Source: Investor's Business Daily. 2008.

Record details

Prices Of Recent IPOs.

• Source: Investor's Business Daily. 2007.

Record details